LYDIA REGAN: Open Payments
NPI 1750977450 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 50 payments from 16 companies in 2025. Trend: 2023 $66 · 2024 $805 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 8 | $339 |
| ABBVIE INC. | 11 | $259 |
| Alkermes, Inc. | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 2 | $83 |
| Gilead Sciences, Inc. | 4 | $82 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Phathom Pharmaceuticals, Inc. | 4 | $69 |
| Indivior Inc. | 2 | $61 |
| Orexo US, Inc. | 3 | $58 |
| Exact Sciences Corporation | 2 | $36 |
Products named: BRIXADI, VRAYLAR, SPRAVATO, INGREZZA, VOQUEZNA, SUBLOCADE, Zubsolv, VIVITROL.
Industry payments across NY — which companies pay providers there.
